ZIC1 and colorectal neoplasm: Additionally, promoter methylation was detected in 85% (34/40) of colorectal tumor tissues, but not in adjacent non-tumor tissues by MSP analysis (the representative data shown in Figure 2B), implying a tumor-specific hypermethylation of the ZIC1 promoter in CRCs.